.svg)
Where There's Blood, There's Signal
.svg)
In this episode, our guests share their career influences, discuss the challenges of managing interdisciplinary teams, and explore the future of neuroimaging and brain-computer interfaces (BCIs). Delving into ultrasound and optical-based techniques, they highlight the transformative potential of non-invasive methods for diagnosing and treating brain conditions. Furthermore, they addresses regulatory hurdles, the evolution of focused research organizations, and offers valuable advice for early-career researchers on leveraging industry trends and fundamental research to drive technological advancements.
Our guests are:
- Sumner Norman, Co-founder and CEO at Forest Neurotech
- Ryan Field, CEO of Kernel
- Mary Lou Jepsen, Founder and CEO of Openwater
Show Notes:
00:00 | Welcome to Neurotech Pub
00:06 | Meet the Guests
02:48 | Balancing Mentorship and Startup Demands
05:36 | Interdisciplinary Challenges in Neurotech
07:11 | Hardware Development and Efficiency
18:12 | Medical Device Development and Regulatory Challenges
23:37 | Technical Deep Dive: Optical and Acoustic Signatures
24:00 | Ultrasound in Brain-Computer Interfaces
34:57 | Near-Infrared Spectroscopy and Mental Health
55:55 | Understanding Stroke and Thrombectomy
56:51 | Innovations in Cancer Treatment and Blood Flow Analysis
57:39 | Challenges and Trials in Medical Technology
58:42 | Open Source Medical Technology and Global Collaboration
58:59 | The Evolution of Brain-Computer Interfaces
01:02:42 | Advancements in Ultrasound Technology
01:03:39 | The Role of MEMS and Silicon in Medical Devices
01:09:29 | The Importance of Fundamental Research
01:14:48 | The Future of Neurotechnology and Industry Trends
01:17:58 | Advice for Aspiring Researchers and Entrepreneurs
01:29:41 | Leadership and Transition in Tech Companies
01:40:07 | Focused Research Organizations and Their Impact
01:46:08 | Final Thoughts and Optimism for Neurotech
Want More?
Follow Neurotech Pub on Twitter
.svg)